Most Read This Week
- Efficacy of Vitamin D Supplementation on Glycaemic Control in Individuals With Type 2 Diabetes
- Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
- The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost
- Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass
- Effects of GLP-1 Receptor Agonists Used as an Adjunct to Insulin Therapy on HbA1c Levels and CGM Metrics in Adults With Type 1 Diabetes
Recently Updated
- Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
- In-Utero Sugar Restriction Cuts Offspring's Risk for Diabetes, Hypertension
- Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
- Proteins and Pathways Associated With Enhanced Insulin Sensitivity Owing to Caloric Restriction
- Prevalence of Diabetes 15.8 Percent in U.S. Adults From 2021 to 2023